4.7 Article

Polymer-Mesoporous Silica Nanoparticle Core-Shell Nanofibers as a Dual-Drug-Delivery System for Guided Tissue Regeneration

期刊

ACS APPLIED NANO MATERIALS
卷 3, 期 2, 页码 1457-1467

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsanm.9b02298

关键词

electrospinning; core-shell nanofibers; mesoporous silica nanoparticles; controlled drug release; guided tissue regeneration

资金

  1. Australian Dental Research Foundation Inc. [243-2017]
  2. HaBS Research Collaboration Seeding Grants
  3. Nature Science Foundation of China [81871503, 81700960]
  4. University of Queensland

向作者/读者索取更多资源

Bioactive membranes with growth factors that mimic the physiological microenvironment of periodontal tissues have shown great potential for guided tissue regeneration (GTR). However, the loss of bioactivity and the uncontrolled drug release in conventional membranes limit their efficacy. In addition, membranes with local infection control ability would provide additional benefits to regeneration. In this work, nanoengineered membranes with growth factor and antibiotic delivery capabilities were developed to achieve dual functions for efficient GTR. Mesoporous silica nanoparticles (MSNs) with large pores with the ability to encapsulate and preserve the bioactivity of growth factors were used as the core, and antibiotics were loaded in shell nanofibers with coaxial electrospinning. A sustained release behavior of the growth factor was observed, and the nanoparticle-encapsulated core-shell nanofibers show better ontogenetic regeneration abilities toward bone marrow stromal cells, compared to current commercial Bio-Gide membranes. In addition, the drug-loaded nanocomposite core-shell nanofibers showed excellent antibacterial properties toward Gram-positive, Gram-negative, and multispecies oral bacteria. The MSNs-embedded core-shell nanofiber system provides an attractive strategy to deliver dual drugs for GTR with better performance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据